30 Aug 2021 --- Yemoja is aiming to commercialize the production of various microalgae candidates for managing inflammation and Inflammatory Bowel Disease (IBD). These will be identified in a four-year research initiative headed by the Israel-based MIGAL Galilee Research Institute.
.jpeg)
